GMP Pharmacopeias – Impurities and Critical Assays: Operational Multi-Region Management ICH vs USP vs Ph. Eur.

Impurities and biological assays are among the leading causes of critical observations during EMA, FDA, and PIC/S inspections.
Not because tests are missing, but because the rationale behind limits, specifications, and analytical choices is missing.

ICH guidelines and Pharmacopeias state what must be done.
During an audit, however, inspectors ask why a specific choice was made – and whether it is defensible.

This guide is designed for QA, QC, QP, and RA professionals working under inspection pressure who must make fast, consistent, and defensible decisions, without wasting days interpreting fragmented regulations.
Its purpose is to save time, not to explain theory.

The Real Problem

In daily practice, this happens all the time:

• Specifications copied from pharmacopeias without real justification
• ICH limits applied “by default,” without assessing the actual manufacturing process
• Compendial methods treated as black boxes, without in-house verification
• Highly variable bioassays that are difficult to explain during inspections
• Delayed decisions because USP, Ph. Eur., and ICH do not fully align

The result?
Documents rewritten multiple times, uncertainty in front of inspectors, rework costing days and putting batch release at risk.

This guide was created precisely from these real-world scenarios.

The Concrete Value You Get

With this guide, you can:

• Drastically reduce audit preparation time for impurities and assays
• Make faster, more defensible decisions on limits and specifications
• Avoid common mistakes that lead to critical findings
• Align ICH, USP, and Ph. Eur. without unnecessary duplication
• Enter audits with clear, ready-to-use rationales

No theoretical benefits.
Real time savings and reduced regulatory risk.

What the Guide Contains

This is not a collection of regulations.
It is an operational tool.

Inside, you will find:

• Practical interpretation of ICH Q3A/B/C/D, M7, Q6A/Q6B
• Operational comparison of USP vs Ph. Eur. on impurities and critical assays
• Clear criteria to define and justify specification limits
• Structured approach to impurities:
  • organic impurities
  • residual solvents
  • elemental impurities
  • genotoxic impurities / nitrosamines
• Practical management of compendial bioassays (variability, validation, trending)
• Audit-ready checklists for QA/QC/QP
• Real inspection error examples – and how to avoid them
• Applied risk-based logic (ICH Q9), ready to be explained during inspections

Each section is designed to be used immediately, not studied.

Why Buy This Guide?

Because it saves you from:

Re-reading dozens of regulatory documents

Re-interpreting ambiguous requirements from scratch

Rebuilding rationales under audit pressure

Rewriting documents because they are “not defensible”

The standards are already interpreted.
The decisions are guided.

If you work in QA/QC, the price of this guide is lower than the cost of a single day lost in audit preparation.

Who It’s For – and Who It’s Not

Ideal for:

• Quality Assurance
• Quality Control
• Qualified Person (QP)
• Regulatory Affairs
• Laboratory Managers
• Validation / Analytical Development

Not suitable for those who:

• Are looking for an introductory explanation of GMP
• Want only a theoretical summary of regulations
• Do not make operational decisions

This guide is written by professionals who have experienced real audits, defended specifications in front of inspectors, and understand the practical differences between EMA and FDA.

Audit-ready. Risk-based.
Aligned with current inspection expectations.
No unnecessary theory – only defensible decisions.

Product Details

• Format: Professional PDF
• Length: 62 pages
• Updated: February 2026
• Languages: ITA – ENG

DOWNLOAD A PREVIEW OF THE GUIDE